MOS
48
-2
PEP
32
2
NFLX
59
-2
DLTR
44
-6
WM
54
4
MKC
53
2
CNX
49
7
BLK
46
2
RHI
40
-3
TRV
42
2
TAP
43
2
DIS
73
-2
LB
64
4
GME
66
-2
UPS
61
5
HIG
48
4
ITW
33
2
EXPD
23
2
MMM
47
2
AMP
52
6
MOS
48
-2
PEP
32
2
NFLX
59
-2
DLTR
44
-6
WM
54
4
MKC
53
2
CNX
49
7
BLK
46
2
RHI
40
-3
TRV
42
2
TAP
43
2
DIS
73
-2
LB
64
4
GME
66
-2
UPS
61
5
HIG
48
4
ITW
33
2
EXPD
23
2
MMM
47
2
AMP
52
6
Financhill
Back

UiPath Vs. Crinetics Pharmaceuticals Industry Stock Comparison

Sell
35

PATH
UiPath

Last Price:
$12.97
Seasonality Move:
-4.65%
Sell
8

CRNX
Crinetics Pharmaceuticals

Last Price:
$40.59
Seasonality Move:
-9.08%
Sell
35
UiPath (PATH) is a Sell

Is UiPath a Buy, Sell or Hold?

  • The current UiPath [PATH] share price is $13.43. The Score for PATH is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • PATH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
8
Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals [CRNX] share price is $48.50. The Score for CRNX is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

PATH Stock Price Chart

What is UiPath's stock price today?

  • The UiPath share price today is $13.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PATH is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals's stock price today?

  • The Crinetics Pharmaceuticals share price today is $48.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight selling pressure.

PATH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 49.84 Sell
Chaikin Money Flow: 5564945 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.9 - 14.6) Sell
Bollinger Bands (100): (12.16 - 13.8) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.69 Sell
Relative Strength Index (14 RSI): 34.32 Sell
Chaikin Money Flow: -235099 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.1 - 56.94) Sell
Bollinger Bands (100): (51.5 - 57.46) Sell

PATH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.12 Buy
20-day SMA: 13.44 Sell
50-day SMA: 13.49 Sell
200-day SMA: 14.43 Sell
8-day EMA: 13.27 Buy
20-day EMA: 13.4 Buy
50-day EMA: 13.4 Buy
200-day EMA: 14.52 Sell

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.85 Sell
20-day SMA: 53.18 Sell
50-day SMA: 55.63 Sell
200-day SMA: 51.03 Sell
8-day EMA: 50.82 Sell
20-day EMA: 52.67 Sell
50-day EMA: 54.22 Sell
200-day EMA: 49.96 Sell

UiPath Earnings Growth & PATH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.00 per share, and an increase next year of $0.03 per share.

Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.

UiPath Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):